A Review of National Guidelines for Management of COPD in Europe
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/2371 |
Resumo: | The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments. |
id |
RCAP_22faf99d3ee18407a987344c9d1df6a7 |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/2371 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
A Review of National Guidelines for Management of COPD in EuropeCHLC PNEUAdrenal Cortex Hormones/therapeutic useBronchodilator Agents/therapeutic useCzech RepublicDisease ManagementEnglandEuropeEvidence-Based MedicineExpectorants/therapeutic useFinlandFranceGermanyItalyPatient Care PlanningPatient SelectionPolandPortugalPractice Guidelines as TopicPulmonary Disease, Chronic Obstructive/diagnosisPulmonary Disease, Chronic Obstructive/drug therapyRussiaSpainSwedenWalesThe quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments.European Respiratory SocietyRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEMiravitlles, MVogelmeier, CRoche, NHalpin, DCardoso, JChuchalin, AKankaanranta, HSandström, TŚliwiński, PZatloukal, JBlasi, F2016-01-26T15:47:36Z2016-01-212016-01-21T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/2371engEur Respir J. 2016 Feb;47(2):625-3710.1183/13993003.01170-2015info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:36:40Zoai:repositorio.chlc.min-saude.pt:10400.17/2371Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:19:43.890433Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
A Review of National Guidelines for Management of COPD in Europe |
title |
A Review of National Guidelines for Management of COPD in Europe |
spellingShingle |
A Review of National Guidelines for Management of COPD in Europe Miravitlles, M CHLC PNEU Adrenal Cortex Hormones/therapeutic use Bronchodilator Agents/therapeutic use Czech Republic Disease Management England Europe Evidence-Based Medicine Expectorants/therapeutic use Finland France Germany Italy Patient Care Planning Patient Selection Poland Portugal Practice Guidelines as Topic Pulmonary Disease, Chronic Obstructive/diagnosis Pulmonary Disease, Chronic Obstructive/drug therapy Russia Spain Sweden Wales |
title_short |
A Review of National Guidelines for Management of COPD in Europe |
title_full |
A Review of National Guidelines for Management of COPD in Europe |
title_fullStr |
A Review of National Guidelines for Management of COPD in Europe |
title_full_unstemmed |
A Review of National Guidelines for Management of COPD in Europe |
title_sort |
A Review of National Guidelines for Management of COPD in Europe |
author |
Miravitlles, M |
author_facet |
Miravitlles, M Vogelmeier, C Roche, N Halpin, D Cardoso, J Chuchalin, A Kankaanranta, H Sandström, T Śliwiński, P Zatloukal, J Blasi, F |
author_role |
author |
author2 |
Vogelmeier, C Roche, N Halpin, D Cardoso, J Chuchalin, A Kankaanranta, H Sandström, T Śliwiński, P Zatloukal, J Blasi, F |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Miravitlles, M Vogelmeier, C Roche, N Halpin, D Cardoso, J Chuchalin, A Kankaanranta, H Sandström, T Śliwiński, P Zatloukal, J Blasi, F |
dc.subject.por.fl_str_mv |
CHLC PNEU Adrenal Cortex Hormones/therapeutic use Bronchodilator Agents/therapeutic use Czech Republic Disease Management England Europe Evidence-Based Medicine Expectorants/therapeutic use Finland France Germany Italy Patient Care Planning Patient Selection Poland Portugal Practice Guidelines as Topic Pulmonary Disease, Chronic Obstructive/diagnosis Pulmonary Disease, Chronic Obstructive/drug therapy Russia Spain Sweden Wales |
topic |
CHLC PNEU Adrenal Cortex Hormones/therapeutic use Bronchodilator Agents/therapeutic use Czech Republic Disease Management England Europe Evidence-Based Medicine Expectorants/therapeutic use Finland France Germany Italy Patient Care Planning Patient Selection Poland Portugal Practice Guidelines as Topic Pulmonary Disease, Chronic Obstructive/diagnosis Pulmonary Disease, Chronic Obstructive/drug therapy Russia Spain Sweden Wales |
description |
The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-01-26T15:47:36Z 2016-01-21 2016-01-21T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/2371 |
url |
http://hdl.handle.net/10400.17/2371 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Eur Respir J. 2016 Feb;47(2):625-37 10.1183/13993003.01170-2015 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
European Respiratory Society |
publisher.none.fl_str_mv |
European Respiratory Society |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131294483873792 |